Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis
Neuropilin-1 (Nrp1) on regulatory T (T reg ) cells is shown to interact with semaphorin-4a (Sema4a) to promote a program of T reg -cell stability and survival, in part through PTEN-mediated modulation of Akt signalling; Nrp1-deficient T reg cells can maintain immune homeostasis but fail to suppress...
Saved in:
Published in | Nature (London) Vol. 501; no. 7466; pp. 252 - 256 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
12.09.2013
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Neuropilin-1 (Nrp1) on regulatory T (T
reg
) cells is shown to interact with semaphorin-4a (Sema4a) to promote a program of T
reg
-cell stability and survival, in part through PTEN-mediated modulation of Akt signalling; Nrp1-deficient T
reg
cells can maintain immune homeostasis but fail to suppress in inflammatory sites, such as tumours, providing an attractive immunotherapeutic target for the treatment of cancers.
Anti-tumour versus pro-immunity effects of T
reg
cells
Regulatory T cells (T
reg
) constitute a barrier to effective anti-tumour immunity. Their depletion can induce reduction and clearance of many tumours, but as the cells perform an important balancing role in the immune system, depletion also results in unchecked autoimmunity and death. This paper describes an interaction between semaphorin-4a — an activator for T-cell-mediated immunity — and the neuropilin receptor Nrp1 on T
reg
cells that is required for T
reg
cells to limit anti-tumour immune responses and to cure established inflammatory colitis, but is dispensable for suppression of autoimmunity and maintenance of immune homeostasis. It remains to be determined whether it is feasible to limit tumour growth by targeting T
reg
cells without unleashing autoimmunity. The two biological activities may be inseparable, but this work points to ways in which this important system can be further characterized.
Regulatory T cells (T
reg
cells) have a crucial role in the immune system by preventing autoimmunity, limiting immunopathology, and maintaining immune homeostasis
1
. However, they also represent a major barrier to effective anti-tumour immunity and sterilizing immunity to chronic viral infections
1
. The transcription factor Foxp3 has a major role in the development and programming of T
reg
cells
2
,
3
. The relative stability of T
reg
cells at inflammatory disease sites has been a highly contentious subject
4
,
5
,
6
. There is considerable interest in identifying pathways that control the stability of T
reg
cells as many immune-mediated diseases are characterized by either exacerbated or limited T
reg
-cell function. Here we show that the immune-cell-expressed ligand semaphorin-4a (Sema4a) and the T
reg
-cell-expressed receptor neuropilin-1 (Nrp1) interact both
in vitro
, to potentiate T
reg
-cell function and survival, and
in vivo
, at inflammatory sites. Using mice with a T
reg
-cell-restricted deletion of Nrp1, we show that Nrp1 is dispensable for suppression of autoimmunity and maintenance of immune homeostasis, but is required by T
reg
cells to limit anti-tumour immune responses and to cure established inflammatory colitis. Sema4a ligation of Nrp1 restrained Akt phosphorylation cellularly and at the immunologic synapse by phosphatase and tensin homologue (PTEN), which increased nuclear localization of the transcription factor Foxo3a. The Nrp1-induced transcriptome promoted T
reg
-cell stability by enhancing quiescence and survival factors while inhibiting programs that promote differentiation. Importantly, this Nrp1-dependent molecular program is evident in intra-tumoral T
reg
cells. Our data support a model in which T
reg
-cell stability can be subverted in certain inflammatory sites, but is maintained by a Sema4a–Nrp1 axis, highlighting this pathway as a potential therapeutic target that could limit T
reg
-cell-mediated tumour-induced tolerance without inducing autoimmunity. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0028-0836 1476-4687 1476-4687 |
DOI: | 10.1038/nature12428 |